UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
CHA Biotech revises separate operating profit to a loss in 2018
CHA Biotech announced Thursday that the company revised its separate operat...
by Jeong Sae-im
|
2019-03-15 16:26
라인
'OliX to target global market with RNA technology'
OliX Pharmaceutical’s RNAi (RNA interference) technology is getting the not...
by Lee Han-soo
|
2019-03-15 11:44
라인
Loss-making Medipost seeks to avoid administrative issue designation
Medipost, a company specializing in stem cell research, is drawing the indu...
by Jeong Sae-im
|
2019-03-14 14:33
라인
Celltrion Healthcare wins biosimilar bids in SE Asia
Celltrion Healthcare said that it won the bids for Singapore’s infliximab b...
by Lee Han-soo
|
2019-03-07 14:25
라인
Biogen seeks gene therapy pipeline for rare eye disease
The biotech industry is paying attention to whether Biogen’s recent acquisi...
by Kim Yun-mi
|
2019-03-06 14:41
라인
Europe OKs Samsung Bioepis’ biosimilar treatment of breast cancer
Samsung Bioepis said Tuesday that the European Medicines Agency has granted...
by Lee Han-soo
|
2019-03-05 17:53
라인
Bridge Biotherapeutics to accelerate global presence
Lee Jung-kue, CEO of Bridge Biotherapeutics, is making noticeable strides i...
by Lee Han-soo
|
2019-03-04 10:50
라인
BioGenetics inks deal to supply biliary tract cancer drug in Korea
BioGenetics said it has signed a deal with Singapore-based drugmaker Aslan ...
by Lee Hye-seon
|
2019-02-28 16:49
라인
Researchers find biomarker to predict recurrence of chronic myeloid leukemia
Korean researchers said they have discovered a biomarker to predict a thera...
by Park Gi-taek
|
2019-02-25 16:03
라인
Celltrion Healthcare posts ₩713.5 billion in 2018 sales
Celltrion Healthcare, a subsidiary of Celltrion, said Friday that it record...
by Lee Han-soo
|
2019-02-22 17:29
라인
Alteogen applies for P1 trial for Eylea biosimilar
Alteogen said Friday that it has filed an investigational new drug applicat...
by Lee Han-soo
|
2019-02-22 16:03
라인
Samsung Bioepis, C-Bridge Capital to develop biosimilars in China
Samsung Bioepis said Monday that it has signed a licensing agreement with C...
by Lee Han-soo
|
2019-02-11 11:23
라인
Samsung BioLogics posts ₩535.8 billion in 2018 sales
Samsung BioLogics said Thursday that it recorded 535.8 billion won ($479 mi...
by Lee Han-soo
|
2019-02-01 11:56
라인
Celltrion to export biosimilars to Latin America
Celltrion Healthcare said Thursday that it has successfully won bids to sup...
by Lee Han-soo
|
2019-01-31 11:12
라인
Samsung Bioepis’ biosimilar sales in EU exceed $500 million
Samsung Bioepis’ biosimilar sales in European Union surpassed $500 million ...
by Lee Han-soo
|
2019-01-30 18:17
라인
KIST finds boiling histotripsy’s mechanism to remove tumor tissue
Local researchers have found how a boiling histotripsy worked to get rid of...
by Cho In-sung
|
2019-01-24 11:30
라인
FDA OKs Samsung Bioepis’ first oncology medicine
Samsung Bioepis said Monday that the U.S. Food and Drug Administration has ...
by Lee Han-soo
|
2019-01-21 11:43
라인
Celltrion wins patent dispute on Truxima
Celltrion said Friday that it has won the domestic patent appeal for chroni...
by Lee Han-soo
|
2019-01-18 11:47
라인
Over 1,000 bio-ventures set up in past 3 years
Korea’s bio-venture business boom peaked in 2016 and turned downward, but a...
by Lee Han-soo
|
2019-01-17 22:05
라인
CL Bio wins patent for substance that improves antidiabetic functions
CL Bio, a local biopharmaceutical firm, said Monday that it has acquired al...
by Lee Han-soo
|
2019-01-14 12:34
-
이전
11
12
13
14
15
16
17
18
19
20
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top